Helen Frankenthaler Foundation

Tetanus toxoid T-helper epitope

Discovery of Mixed Pharmacology Melanocortin-3 Agonists and Melanocortin-4 Receptor Tetrapeptide Antagonist Compounds (TACOs) Based on the Sequence Ac-Xaa1-Arg-(pI)DPhe-Xaa4-NH2

Article Information

Article April 28, 2017

  • Skye R. Doering†
  • Katie T. Freeman†
  • Sathya M. Schnell†
  • Erica M. Haslach‡
  • Marvin Dirain‡
  • Ginamarie Debevec§
  • Phaedra Geer§
  • Radleigh G. Santos§
  • Marc A. Giulianotti§
  • Clemencia Pinilla∥
  • Jon R. Appel∥
  • Robert C. Speth⊥̈#
  • Richard A. Houghten§∥
  • Carrie Haskell-Luevano*†‡

View Author Information

Journal of Medicinal Chemistry

Cite this: J. Med. Chem. 2017, 60, 10

Click to copy citation Citation copied!

Published April 28, 2017

research-article

Copyright © 2017 American Chemical Society

Abstract

Click to copy section link Section link copied!

The centrally expressed melanocortin-3 and -4 receptors (MC3R/MC4R) have been studied as possible targets for weight management therapies, with a preponderance of studies focusing on the MC4R. Herein, a novel tetrapeptide scaffold [Ac-Xaa 1-Arg-(pI)DPhe-Xaa 4-NH 2] is reported. The scaffold was derived from results obtained from a MC3R mixture-based positional scanning campaign. From these results, a set of 48 tetrapeptides were designed and pharmacologically characterized at the mouse melanocortin-1, -3, -4, and -5 receptors. This resulted in the serendipitous discovery of nine compounds that were MC3R agonists (EC 50< 1000 nM) and MC4R antagonists (5.7 < pA 2< 7.8). The three most potent MC3R agonists, 18 [Ac-Arg-Arg-(pI)DPhe-Tic-NH 2], 1 [Ac-His-Arg-(pI)DPhe-Tic-NH 2], and 41 [Ac-Arg-Arg-(pI)DPhe-DNal(2′)-NH 2] were more potent (EC 50< 73 nM) than the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH 2. This template contains a sequentially reversed “Arg-(pI)DPhe” motif with respect to the classical “Phe-Arg” melanocortin signaling motif, which results in pharmacology that is first-in-class for the central melanocortin receptors.

ACS Publications

Copyright © 2017 American Chemical Society

Supporting Information

Click to copy section link Section link copied!

The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.jmedchem.7b00301.

  • Analytical information for the single tetrapeptides synthesized and characterized in this study; purity for these compounds is >95% (PDF)
  • Molecular formula strings and the associated biochemical and biological data for the single tetrapeptides (CSV)
  • jm7b00301_si_001.csv (10.44 kb)
  • jm7b00301_si_002.pdf (720.3 kb)
Terms & Conditions

Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: https://www.frankenthalerfoundation.org

Cited By

Click to copy section link Section link copied!

This article is cited by 15 publications.

  1. Nicholas A. Weirath, Jonathan W. P. Zajac, Haley M. Donow, Travis M. Lavoi, Clemencia Pinilla, Radleigh G. Santos, Ritu Prajapati, Robert Speth, Mark D. Ericson, Sapna Sarupria, Marcello A. Giulianotti, Carrie Haskell-Luevano. N-Branched Tricyclic Guanidines as Novel Melanocortin-3 Receptor Agonists and Melanocortin-4 Receptor Antagonists. Journal of Medicinal Chemistry2025, 68 (3) , 2504-2527. https://www.frankenthalerfoundation.org
  2. Nicholas A. Weirath, Carrie Haskell-Luevano. Recommended Tool Compounds for the Melanocortin Receptor (MCR) G Protein-Coupled Receptors (GPCRs). ACS Pharmacology & Translational Science2024, 7 (9) , 2706-2724. https://www.frankenthalerfoundation.org
  3. Mark D. Ericson, Courtney M. Larson, Katie T. Freeman, Lennart Nicke, Armin Geyer, Carrie Haskell-Luevano. Incorporation of Indoylated Phenylalanine Yields a Sub-Micromolar Selective Melanocortin-4 Receptor Antagonist Tetrapeptide. ACS Omega2022, 7 (31) , 27656-27663. https://www.frankenthalerfoundation.org
  4. Mark D. Ericson, Skye R. Doering, Courtney M. Larson, Katie T. Freeman, Travis M. LaVoi, Haley M. Donow, Radleigh G. Santos, Rachel H. Cho, Zoe M. Koerperich, Marc A. Giulianotti, Clemencia Pinilla, Richard A. Houghten, Carrie Haskell-Luevano. Functional Mixture-Based Positional Scan Identifies a Library of Antagonist Tetrapeptide Sequences (LAtTeS) with Nanomolar Potency for the Melanocortin-4 Receptor and Equipotent with the Endogenous AGRP(86-132) Antagonist. Journal of Medicinal Chemistry2021, 64 (19) , 14860-14875. https://www.frankenthalerfoundation.org
  5. Skye R. Doering, Katie Freeman, Ginamarie Debevec, Phaedra Geer, Radleigh G. Santos, Travis M. Lavoi, Marc A. Giulianotti, Clemencia Pinilla, Jon R. Appel, Richard A. Houghten, Mark D. Ericson, Carrie Haskell-Luevano. Discovery of Nanomolar Melanocortin-3 Receptor (MC3R)-Selective Small Molecule Pyrrolidine Bis-Cyclic Guanidine Agonist Compounds Via a High-Throughput “Unbiased” Screening Campaign. Journal of Medicinal Chemistry2021, 64 (9) , 5577-5592. https://www.frankenthalerfoundation.org
  6. Mark D. Ericson, Romessa Shaikh, Courtney M. Larson, Katie T. Freeman, Carrie Haskell-Luevano. Multiresidue Tetrapeptide Substitutions Yield a 140-fold Selective Melanocortin-3 over Melanocortin-4 Receptor Agonist. ACS Medicinal Chemistry Letters2021, 12 (1) , 115-120. https://www.frankenthalerfoundation.org
  7. Zoe M. Koerperich, Mark D. Ericson, Katie T. Freeman, Robert C. Speth, Irina D. Pogozheva, Henry I. Mosberg, Carrie Haskell-Luevano. Incorporation of Agouti-Related Protein (AgRP) Human Single Nucleotide Polymorphisms (SNPs) in the AgRP-Derived Macrocyclic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Decreases Melanocortin-4 Receptor Antagonist Potency and Results in the Discovery of Melanocortin-5 Receptor Antagonists. Journal of Medicinal Chemistry2020, 63 (5) , 2194-2208. https://www.frankenthalerfoundation.org
  8. Marshall D. Winget, Mark D. Ericson, Katie T. Freeman, Carrie Haskell-Luevano. Single Nucleotide Polymorphisms in the Melanocortin His-Phe-Arg-Trp Sequences Decrease Tetrapeptide Potency and Efficacy. ACS Medicinal Chemistry Letters2020, 11 (3) , 272-277. https://www.frankenthalerfoundation.org
  9. Katlyn A. Fleming, Katie T. Freeman, Mike D. Powers, Radleigh G. Santos, Ginamarie Debevec, Marc A. Giulianotti, Richard A. Houghten, Skye R. Doering, Clemencia Pinilla, Carrie Haskell-Luevano. Discovery of Polypharmacological Melanocortin-3 and -4 Receptor Probes and Identification of a 100-Fold Selective nM MC3R Agonist versus a μM MC4R Partial Agonist. Journal of Medicinal Chemistry2019, 62 (5) , 2738-2749. https://www.frankenthalerfoundation.org
  10. Mainak Bardhan, Ayush Anand, Amaan Javed, Maria Andrea Chilo, Nida Khan, Tulika Garg, Arihant Surana, Helen Huang, M M Samim, Vinay Suresh, Abhinav Khare, Bindu Menon, Tithishri Kundu. Polymorphism of Melanocortin Receptor Genes—Association with Inflammatory Traits and Diseases. Diseases2025, 13 (9) , 305. https://www.frankenthalerfoundation.org
  11. Samuel Gary, Anuradha Roy, Steven Bloom. Carbocyclic setmelanotide analogs maintain biochemical potency at melanocortin 4 receptors. Journal of Peptide Science2025, 31 (2) https://www.frankenthalerfoundation.org
  12. Mark D. Ericson, Katie T. Freeman, Travis M. LaVoi, Haley M. Donow, Radleigh G. Santos, Marc A. Giulianotti, Clemencia Pinilla, Richard A. Houghten, Carrie Haskell-Luevano. The Parallel Structure–Activity Relationship Screening of Three Compounds Identifies the Common Agonist Pharmacophore of Pyrrolidine Bis-Cyclic Guanidine Melanocortin-3 Receptor (MC3R) Small-Molecule Ligands. International Journal of Molecular Sciences2023, 24 (12) , 10145. https://www.frankenthalerfoundation.org
  13. Patrick Sweeney, Michelle N. Bedenbaugh, Jose Maldonado, Pauline Pan, Katelyn Fowler, Savannah Y. Williams, Luis E. Gimenez, Masoud Ghamari-Langroudi, Griffin Downing, Yijun Gui, Colleen K. Hadley, Stephen T. Joy, Anna K. Mapp, Richard B. Simerly, Roger D. Cone. The melanocortin-3 receptor is a pharmacological target for the regulation of anorexia. Science Translational Medicine2021, 13 (590) https://www.frankenthalerfoundation.org
  14. Patrick Sweeney, Can Chen, Indika Rajapakse, Roger D. Cone. Network dynamics of hypothalamic feeding neurons. Proceedings of the National Academy of Sciences2021, 118 (14) https://www.frankenthalerfoundation.org
  15. Katherine N. Schlasner, Mark D. Ericson, Skye R. Doering, Katie T. Freeman, Mary Weinrich, Carrie Haskell-Luevano. Structure–Activity Relationships of the Tetrapeptide Ac-His-Arg-(pI)DPhe-Tic-NH2 at the Mouse Melanocortin Receptors: Modification at the (pI)DPhe Position Leads to mMC3R Versus mMC4R Selective Ligands. Molecules2019, 24 (8) , 1463. https://www.frankenthalerfoundation.org

Journal of Medicinal Chemistry

Cite this: J. Med. Chem. 2017, 60, 10

Click to copy citation Citation copied!

Published April 28, 2017

Copyright © 2017 American Chemical Society

Article Views

1389

Altmetric

Learn about these metrics

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

Citations are the number of other articles citing this article, calculated by Crossref and updated daily.Find more information about Crossref citation counts.

The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information onthe Altmetric Attention Score and how the score is calculated.